Efficacy and safety of PEG-rhG-CSF in primary and secondary prevention of chemotherapy-induced neutropenia.

被引：0
|
作者：
Zhu, Jun
Li, Huiping
Fan, Zhengfu
Gao, Yunong
Tu, Meifeng
Shao, Bin
Gao, Tian
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19051
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: A multicenter, prospective, randomized study
    Sun, Xu-Sheng
    Wang, Zhe
    Ren, Shu-Hua
    Zhang, He-Lin
    Liu, Li-Jun
    Du, Hong-Bo
    Liu, Xiao-Wei
    Liu, Jun-Feng
    THORACIC CANCER, 2022, 13 (17) : 2429 - 2435
  • [22] PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia
    Jin, Shumin
    Chang, Mengyuan
    Feng, Lei
    Hao, Yiping
    Li, Wei
    Zhou, Ying
    Jia, Ruinan
    Liu, Tingting
    Zhang, Di
    Jiang, Huihui
    Wang, Jingtao
    Zhao, Chuanli
    Ji, Chunyan
    Ye, Jingjing
    Ji, Min
    ANNALS OF HEMATOLOGY, 2025, : 1039 - 1046
  • [23] Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study
    Huang, Junting
    Zhu, Jia
    Jiang, Lian
    Xu, Jiaqian
    Lin, Xiheng
    Chang, Jian
    Zhang, Xiaohong
    Lu, Suying
    Sun, Feifei
    Wang, Juan
    Que, Yi
    Ye, Zhonglv
    Yang, Lihua
    Yuan, Xiuli
    Cai, Weisong
    Tian, Chuan
    Wu, Yanpeng
    He, Xiangling
    Tang, Yan-Lai
    Zhang, Yizhuo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [24] Early discharge of children hospitalized for fever and chemotherapy-induced neutropenia. 663
    David N Korones
    Margaret R Hussong
    Michelle A Gullace
    Pediatric Research, 1997, 41 (Suppl 4) : 113 - 113
  • [25] Prospective clinical study of the efficacy and safety of different doses of PEG recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for preventing leukopenia/neutropenia caused by concurrent chemoradiotherapy for cervical cancer
    Tingting Yu
    Yiwei Zhang
    Jiawen Li
    Zhuo Li
    Rui Tong
    Holistic Integrative Oncology, 3 (1):
  • [26] Efficacy and safety of pegteograstim and pegfilgrastim on chemotherapy-induced neutropenia in ovary cancer patients
    Kim, M. K.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 357 - 357
  • [27] Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors
    Cho, Hee Won
    Lee, Ji Won
    Ju, Hee Young
    Hyun, Ju Kyung
    Yoo, Keon Hee
    Koo, Hong Hoe
    Kim, Kyunga
    Sung, Ki Woong
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (02) : E362 - E367
  • [28] A COMPARISON OF EFFICACY OF GM-CSF VERSUS G-CSF IN THE THERAPEUTIC SETTING OF CHEMOTHERAPY-INDUCED NEUTROPENIA
    MILLER, JA
    BEVERIDGE, RA
    BLOOD, 1994, 84 (10) : A22 - A22
  • [29] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing granulocytopenia in sarcoma patients receiving doxorubicin combined with ifosfamide: A prospective, randomized, non-inferiority phase II study.
    Fan, Li
    Ye, Ting
    Wang, Zhongliang
    Cao, Rubo
    Wang, Bicheng
    Peng, Ling
    Chen, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Prevention and Treatment of Chemotherapy-Induced Febrile Neutropenia in Adults
    Park, Hye Min
    Pom, Boramey
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2023, 48 (04)
12345